Gold and Silver Nanoparticles: Versatile Tools in Medicine and Biotechnology

Abstract

Introduction

Gold (Au) and silver (Ag) nanoparticles are metallic nanostructures with dimensions typically ranging from 1 to 100 nanometers. Their unique physicochemical properties, including high surface area, optical characteristics, and tunable size and shape, make them valuable in medicine, biotechnology, and environmental applications. Gold and silver nanoparticles (AuNPs and AgNPs) are increasingly used for drug delivery, imaging, diagnostics, antimicrobial therapy, and biosensing. Their nanoscale dimensions allow enhanced interaction with biological systems, enabling targeted and efficient therapeutic and diagnostic applications [1].

Discussion

One of the primary advantages of gold and silver nanoparticles is their optical and electronic properties. Gold nanoparticles exhibit strong surface plasmon resonance (SPR), allowing their use in imaging, photothermal therapy, and biosensing. They can absorb light at specific wavelengths and convert it into heat, a feature exploited in cancer photothermal therapy to selectively destroy tumor cells while minimizing damage to surrounding healthy tissues. Silver nanoparticles, renowned for their antimicrobial activity, are effective against bacteria, fungi, and viruses. Their mechanisms include generation of reactive oxygen species (ROS), disruption of microbial cell membranes, and interaction with microbial DNA, making them valuable in wound care, coatings, and infection control [2].

Drug delivery is another major application. Gold nanoparticles can be functionalized with ligands, antibodies, peptides, or drugs to achieve targeted delivery and controlled release. This surface modification enables selective binding to cancer cells or infected tissues, enhancing therapeutic efficacy and reducing systemic toxicity. Silver nanoparticles, while primarily used for antimicrobial purposes, are also being explored for co-delivery with antibiotics to improve their effectiveness and reduce the development of resistance [3].

Diagnostic and biosensing applications leverage the unique optical and electronic properties of AuNPs and AgNPs. Gold nanoparticles are used in colorimetric assays, lateral flow tests, and imaging techniques for early detection of diseases such as cancer, viral infections, and cardiovascular disorders. Silver nanoparticles enhance signal amplification in biosensors due to their high conductivity, improving sensitivity and detection limits [4].

In addition to medical applications, gold and silver nanoparticles contribute to theranostics, combining therapeutic and diagnostic capabilities. For example, functionalized gold nanoparticles can simultaneously deliver anticancer drugs and allow real-time monitoring of tumor localization through imaging. Similarly, silver nanoparticles incorporated into wound dressings provide antimicrobial activity while enabling visualization of infection sites [5].

Conclusion

Gold and silver nanoparticles are versatile nanomaterials with significant potential in medicine, biotechnology, and diagnostics. Their unique optical, electronic, and antimicrobial properties enable applications in targeted drug delivery, imaging, photothermal therapy, antimicrobial treatments, and biosensing. Functionalization strategies further enhance their specificity, safety, and therapeutic potential. While challenges in toxicity, stability, and regulatory approval remain, ongoing research and technological advances continue to expand the biomedical applications of AuNPs and AgNPs [6].

References

1. Schneider LS, Dagerman KS, Insel P (2005) Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia. JAMA 294: 1934–1943.

   Indexed at, Google Scholar, Crossref

2. Rasmussen K, Sampson S, Rummans T (2002) Electroconvulsive therapy and newer modalities for the treatment of medication-refractory mental illness. Mayo Clin Proc 77: 552–556.

   Indexed at, Google Scholar, Crossref

3. Lotrich F, Pollock B (2005) Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol 45: 1106–1122.

   Indexed at, Google Scholar, Crossref

4. Olesen JB, Hansen PR, Erdal J, Abildstrøm SZ, Weeke P, et al. (2010) Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidem Dr S 19: 518–524.

   Indexed at, Google Scholar, Crossref

5. Gill S, Bronskill S, Normand S, Anderson GM, Sykora K, et al. (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146: 775–786.

   Indexed at, Google Scholar, Crossref